随着中医药治疗在新型冠状病毒肺炎（COVID-19）疫情防控中的广泛使用和不断推进，中医药对COVID-19的防治取得了许多创新成果。及时把相关创新成果的专利信息进行梳理和分析，一方面有利于科研工作者更快速地利用专利情报挖掘和筛选更有效的药物，另一方面也有助于启发研发人员加强创新成果的专利保护。以国家卫生健康委员会发布的《新型冠状病毒肺炎诊疗方案（试行第六版）》为主线，对用于医学观察期的推荐中成药以及用于临床治疗期的基础方剂、推荐处方和推荐中成药的相关专利信息进行梳理分析，阐述推荐处方和推荐中成药的专利技术路线，并进行重点专利信息分析，试图为中医药科研工作提供有益参考。

With the wide application and constantly advancing of traditional Chinese medicine(TCM) in the prevention and control of COVID-19, many innovative achievements have been made in the prevention and treatment of COVID-19 by TCM. Analyzing the patent information of related innovations timely will not only help researcher to use patent information more quickly to mine and screen more effective drugs, but also help inspiring R&D personnel to strengthen patent protection for innovations. This article is based on Chinese Clinical Guidance for COVID-19 Diagnosis and Treatment (6th edition) published by National Health Commitssion of the People's Republic of China, analyses related patent information on recommended Chinese patent medicines in medical observation period, and basic prescriptions, recommended prescriptions and recommended Chinese patent medicines in clinical treatment period, describes the patent technology roadmap of recommended prescriptions and recommended Chinese patent medicines, analyzes key patent information, and tries to provide useful reference for scientific research of TCM.

R288